bluebird bio, Inc. (BLUE)

bluebird bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-240.72	-211.91	-230.34	-819.38	-618.7
Depreciation & Amortization	61.24	28.53	8.34	5.45	5.63
Loss (Gain) From Sale of Investments	-	-	3.14	-29.36	7.22
Stock-Based Compensation	13.74	19.43	35.09	127.92	156.63
Other Operating Activities	35.76	-21.37	-57.4	47.55	-6.01
Change in Inventory	-52.46	-36.56	-7.23	-18.45	-
Change in Accounts Payable	16.5	2.84	-7.71	9.29	-20.1
Change in Other Net Operating Assets	-94.09	-16	-60.11	27.15	-8.75
Operating Cash Flow	-260.02	-235.05	-316.22	-635.64	-470.35
Capital Expenditures	-2.6	-4.19	-8.21	-14.5	-28.99
Divestitures	-	-	-	110.3	-
Sale (Purchase) of Intangibles	-	-4.87	-5	-8.5	-
Investment in Securities	-	71.08	161.66	475.26	-55.36
Other Investing Activities	6.5	92.93	102	-	-
Investing Cash Flow	3.9	154.95	250.45	562.56	-84.35
Short-Term Debt Issued	71.32	-	-	-	-
Total Debt Issued	71.32	-	-	-	-
Long-Term Debt Repaid	-85.95	-54.37	-36.73	-	-
Net Debt Issued (Repaid)	-14.63	-54.37	-36.73	-	-
Issuance of Common Stock	-	248.2	54.24	80.33	546.72
Other Financing Activities	102.1	2.42	0.02	-174.28	-
Financing Cash Flow	87.47	196.25	17.52	-93.95	546.72
Net Cash Flow	-168.65	116.15	-48.25	-167.04	-7.98
Free Cash Flow	-262.62	-239.24	-324.43	-650.14	-499.34
Free Cash Flow Margin	-313.36%	-811.05%	-9019.38%	-17753.74%	-
Free Cash Flow Per Share	-27.11	-43.57	-82.57	-188.69	-160.62
Cash Income Tax Paid	-0.01	-0.04	0.25	0.62	0.36
Levered Free Cash Flow	-112.87	-137.32	-174.74	164.76	-749.42
Unlevered Free Cash Flow	-98.76	-127.1	-170.79	164.76	-749.42
Change in Net Working Capital	3.83	13.33	47.74	-434.26	499.12

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q